Management of Varicose Veins
Sprache: D/E Slides: E
-
One Size Fits None? – Personalized Treatment Strategies in Varicose Vein Management
- Presentation time:
- 7 min
- Discussion time:
- 5 min
Speaker: Heiko Uthoff (Luzern)
-
Standard Operating Procedures for Post-Treatment Care and Follow-Up After Endovenous Therapy
- Presentation time:
- 7 min
- Discussion time:
- 5 min
Speaker: Siamak Pourhassan (Oberhausen)
-
Management Strategies for Recurrent Varicose Veins
- Presentation time:
- 7 min
- Discussion time:
- 5 min
Speaker: Jürg Traber (Kreuzlingen)
-
Varicose Vein Surgery in the Endovenous Era- Obsolete or Indispensable?
- Presentation time:
- 7 min
- Discussion time:
- 5 min
Speaker: Jürg Traber (Kreuzlingen)
-
Do Perforator Veins Require Treatment – And If So, Which and How?
- Presentation time:
- 7 min
- Discussion time:
- 5 min
-
Prevalence and Incidence of Lower Extremity Venous Disease in Professional Football Players / Athletes (SportsVeinRegistry)
- Presentation time:
- 7 min
- Discussion time:
- 5 min
Presenting Author: Roman Gähwiler (Rheinfelden)
Objective
The literature about the prevalence of venous thrombosis and venous disease in athletes is scarce. Studies suggest that the prevalence of deep vein thrombosis in elite soccer players is higher than expected. Therefore, the prevalence of deep vein thrombosis in the general population between 18-35 years of age is about 1/10’000. Within a cohort of elite football players it seems to be around 1/1’000 in reference to the same age group. As a matter of fact, literature about the prevalence and assessment of superficial venous disease and thromboembolism in lower extremities of professional football players is underrepresented.
Methods
This prospective cross-sectional study is going to evaluate the prevalence and incidence of these entities in a cohort of professional football players within a defined observation period of one year (season 2025-2026). Athletes will be asked about their personal history with regard to venous thromboembolism, their family history, and they will be classified on behalf the revised venous clinical severity score (VCSS). The venous clinical severity score (VCSS) is used to assess those with venous disease. Furthermore, patient history will be supplemented by clinical examination, laboratory testing (d-dimer, etc.), digital photoplethysmography measurements and extensive duplex ultrasound evaluation of the deep, superficial and perforator vein system of both legs. The first cross-sectional assessment will take place in the summer break 2025 (evaluation of prevalence) followed by the second assessment one year later during summer season break 2026.
Results
To be determined (study is going to start as soon as ethical committee approves it)
Conclusion
As far as the authors of this study are concerned, there is almost no literature regarding the prevalence of superficial venous thrombosis, muscle vein thrombosis, or insufficiency of perforator veins and superficial veins (great saphenous and small saphenous vein) in the lower extremities of professional football players and athletes. Furthermore, we assume a significant amount of "non-diagnosed" muscle and superficial vein thrombosis in contact sports such as football players. The primary aim of this study is to get an idea of the prevalence and incidence of venous disease in professional athletes.